Principal Street Partners, LLC Abbott Laboratories Transaction History

Principal Street Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	BUY	$95.06 - $111.52 $44,488 - $52,191	468 Added 21.36%	2,659 $291,000
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $75,182 - $87,047	-777 Reduced 26.18%	2,191 $212,000
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $116,155 - $140,395	1,138 Added 62.19%	2,968 $322,000
Q1 2022 May 05, 2022	SELL	$114.02 - $139.04 $59,062 - $72,022	-518 Reduced 22.06%	1,830 $217,000
Q4 2021 Feb 07, 2022	BUY	$115.53 - $141.46 $28,882 - $35,365	250 Added 11.92%	2,348 $330,000
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $244,752 - $270,767	2,098 New	2,098 $248,000

3,361

1.36B

10.6M

8.73M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $236B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Principal Street Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Principal Street Partners, LLC with notifications on news.